Baseline Carcinoembryonic Antigen as a Predictive Factor of Ramucirumab Efficacy in RAISE, a Second-Line Metastatic Colorectal Carcinoma Phase III Trial
European Journal of Cancer - United Kingdom
doi 10.1016/j.ejca.2017.03.007
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
Elsevier BV